everolimus zentiva 10 mg tabletten
everolimus zentiva 10 mg comprimés
kisplyx
eisai gmbh - lenvatinib mesilato - carcinoma, cellule renali - agenti antineoplastici - kisplyx is indicated for the treatment of adults with advanced renal cell carcinoma (rcc):in combination with pembrolizumab, as first-line treatment (see section 5. in combination with everolimus, following one prior vascular endothelial growth factor (vegf)-targeted therapy.
promus element plus monorail btk everolimus-eluting stent system
boston scientific corporation - stent vascolari periferici a cessione di farmaco (des)
promus element plus over-the-wire btk everolimus-eluting stent system
boston scientific corporation - stent vascolari periferici a cessione di farmaco (des)
xience v everolimus eluting coronary stent system
abbott vascular, cardiac therapies - stent coronarici a cessione di farmaco (des)
xience v everolimus eluting coronary stent system
abbott vascular, cardiac therapies - stent coronarici a cessione di farmaco (des)
xience prime ll everolimus eluting coronary stent system
abbott vascular inc. - stent coronarici a cessione di farmaco (des)
xience prime everolimus eluting coronary stent system
abbott vascular inc. - stent coronarici a cessione di farmaco (des)
xience prime sv everolimus eluting coronary stent system
abbott vascular inc. - stent coronarici a cessione di farmaco (des)